products
    urokinase
    urokinase

    • CAS NO

      9039-53-6

    • Source

      Proteases extracted from healthy human urine or prepared by gene recombination technology

    • Mechanism of action

      Directly activate plasminogen → convert into plasminogen → dissolve thrombus (fibrin)

    • Main uses

      Acute myocardial infarction, pulmonary embolism, cerebral vascular embolism, limb arterial embolism.. Catheter thrombolysis and clearance of ocular hemorrhage.

    Ulinastatin
    Ulinastatin

    • CAS NO

      80449-31-6

    • Source

      Protease inhibitors extracted from human urine

    • Mechanism of action

      Inhibits various hydrolytic enzymes such as trypsin and elastase → reduces inflammation and tissue damage.. Stabilize lysosomal membranes and protect organ function.

    • Main uses

      Acute pancreatitis, chronic recurrent pancreatitis.. Organ protection for shock, extensive trauma, and cardiopulmonary surgery. Assistive treatment for sepsis.

    Human Chorionic Gonadotropin
    Human Chorionic Gonadotropin

    • CAS NO

      9002-61-3

    • Source

      Urine extraction or gene recombination in pregnant women

    • Mechanism of action

      Simulating the action of luteinizing hormone (LH) → ovulation induction/luteinization. Stimulate testicular interstitial cells → promote testosterone synthesis and sperm maturation.

    • Main use

      Women: Triggering ovulation and supporting corpus luteum function in assisted reproductive technology (IVF).

      Male: Hypogonadotropic hypogonadism (testosterone, spermatogenesis).

      Cryptorchidism (in children)

    Human Menopausal Gonadotropin
    Human Menopausal Gonadotropin

    • CAS NO

      97048-13-0

    • Source

      Urine extraction from postmenopausal women (containing FSH+LH)

    • Mechanism of action

      FSH dominates → stimulates follicle development and sperm production.. LH assists → synergistically promotes sex hormone synthesis.

    • Main uses

      Women: anovulatory infertility (such as polycystic ovary syndrome), IVF ovulation induction.

      Male: Hypogonadotropic oligospermia (combined with HCG).

      总计1页 [ 1 ]上一页 下一页
    company logo
    Breakthrough through scientific research to extract difficult problems
    Massive production and partners to expand the vast world together